RG-6182

N/A

Report date: 2024/02/02 17:52:14
NME

Base Information

Drug NameRG-6182
Drug Alias NameRG-6182RG6182
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitors
TargetsMonoglyceride lipase
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A